Kavar Capital Partners Group, LLC Edwards Lifesciences Corp Transaction History

Kavar Capital Partners Group, LLC

$630 Million
Q3 2024

A detailed history of Kavar Capital Partners Group, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Kavar Capital Partners Group, LLC holds 10,877 shares of EW stock, worth $737,025. This represents 0.11% of its overall portfolio holdings.

Number of Shares

10,877

Previous 12,294 11.53%

Holding current value

$737,025

Previous $1.14 Million 36.83%

% of portfolio

0.11%

Previous 0.21%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$59.7 - $93.78 $84,594 - $132,886	-1,417 Reduced 11.53%	10,877 $717,000
Q2 2024 Jul 19, 2024	SELL	$84.3 - $94.31 $91,887 - $102,797	-1,090 Reduced 8.14%	12,294 $1.14 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $1.07 Million - $1.41 Million	-14,764 Reduced 52.45%	13,384 $1.28 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $451,038 - $568,347	7,309 Added 35.07%	28,148 $2.15 Million
Q3 2023 Nov 06, 2023	SELL	$69.28 - $93.38 $86,253 - $116,258	-1,245 Reduced 5.64%	20,839 $1.44 Million
Q2 2023 Aug 07, 2023	SELL	$81.41 - $94.33 $42,903 - $49,711	-527 Reduced 2.33%	22,084 $2.08 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $34,902 - $39,719	-470 Reduced 2.04%	22,611 $1.87 Million
Q4 2022 Feb 10, 2023	SELL	$68.3 - $87.44 $291,641 - $373,368	-4,270 Reduced 15.61%	23,081 $1.72 Million
Q3 2022 Nov 08, 2022	BUY	$82.37 - $107.29 $17,215 - $22,423	209 Added 0.77%	27,351 $2.26 Million
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $100,599 - $149,178	1,163 Added 4.48%	27,142 $2.58 Million
Q1 2022 May 09, 2022	BUY	$101.96 - $128.34 $14,580 - $18,352	143 Added 0.55%	25,979 $3.06 Million
Q4 2021 Jan 27, 2022	BUY	$106.37 - $130.68 $51,163 - $62,857	481 Added 1.9%	25,836 $3.35 Million
Q3 2021 Nov 01, 2021	BUY	$102.91 - $122.75 $24,183 - $28,846	235 Added 0.94%	25,355 $2.87 Million
Q2 2021 Aug 02, 2021	BUY	$83.84 - $104.76 $59,945 - $74,903	715 Added 2.93%	25,120 $2.6 Million
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $11,408 - $13,147	145 Added 0.6%	24,405 $2.04 Million
Q4 2020 Feb 05, 2021	BUY	$71.69 - $91.23 $1.74 Million - $2.21 Million	24,260 New	24,260 $2.21 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kavar Capital Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kavar Capital Partners Group, LLC with notifications on news.

Account

Kavar Capital Partners Group, LLC Edwards Lifesciences Corp Transaction History